Excerpt: What is the status of DOC-IG investigative performance? Has it been improving or declining? Has it been affected by controversies and disputes between some current or former DOC law enforcement agents and the DOC-IG management? Has performance been affected by certain personnel practices?;
Excerpt: It is our understanding that the NRC has a track record of producing cost estimates for its requirements on nuclear power reactors that can be egregiously off target from the actual costs of implementing the requirements.
To read the letter, click here.
Exceprt: Since the week of February 18, 2013, through the last available listing in April 2013, the FDA's Public Calendar has listed Dr. Brenner-Gati as the Acting Deputy Commissioner for Medical Products and Tobacco with no significant meetings.
Exceprt: The award —at $100.6 million, one of the largest broadband grants under the ARRA — has been a source of controversy.
Excerpt: We continue to have questions about how CPPW funds have been spent by HHS. The Committee supports initiatives designed to improve health outcomes and reduce chronic diseases.